CERIANNA is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Zionexa Us Corporation. The primary component is Fluoroestradiol F-18.
Product ID | 72874-001_b47e1c0b-1d74-7b1d-e053-2995a90aded8 |
NDC | 72874-001 |
Product Type | Human Prescription Drug |
Proprietary Name | CERIANNA |
Generic Name | Fluoroestradiol F 18 |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2020-05-20 |
Marketing Category | NDA / NDA |
Application Number | NDA212155 |
Labeler Name | Zionexa US Corporation |
Substance Name | FLUOROESTRADIOL F-18 |
Active Ingredient Strength | 100 mCi/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-05-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212155 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-05-20 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CERIANNA 88625202 not registered Live/Pending |
ZIONEXA 2019-09-20 |